L'Occitane International SA
HKEX:973
L'Occitane International SA
HKEX:973
Price:
33.7
HKD
Market Closed
Market Cap:
HK$49.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
L'Occitane International SA
HKEX:973
|
LU |
|
C
|
Cardinal Health Inc
LSE:0HTG
|
US |
Relative Value
There is not enough data to reliably calculate the relative value of L'Occitane International SA.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
Not Available
Multiples Across Competitors
Competitors Multiples
L'Occitane International SA Competitors
L'Occitane International SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| LU |
|
L'Occitane International SA
HKEX:973
|
49.7B HKD | 2.1 | 57.5 | 12.2 | 19 | |
| FR |
|
L'Oreal SA
PAR:OR
|
183.8B EUR | 4.2 | 30.3 | 18.4 | 22.3 | |
| UK |
|
Unilever PLC
LSE:ULVR
|
98.9B GBP | 2.3 | 12.1 | 12.1 | 13.7 | |
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
4.8T INR | 7.6 | 33.8 | 32.4 | 35.8 | |
| UK |
|
HALEON PLC
LSE:HLN
|
32.6B GBP | 3 | 19.5 | 13.6 | 15.5 | |
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
28.7B USD | 2 | -161.1 | 14.8 | 23.4 | |
| DE |
|
Beiersdorf AG
XETRA:BEI
|
15.9B EUR | 1.6 | 17 | 8 | 9.9 | |
| JP |
|
Kao Corp
TSE:4452
|
2.7T JPY | 1.6 | 22.6 | 10.3 | 15.8 | |
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1T INR | 6.8 | 57 | 34.4 | 37.5 | |
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD | 855.7 | -4 624.4 | -6 373.4 | -6 360.4 | |
| IN |
|
Dabur India Ltd
NSE:DABUR
|
740.2B INR | 5.8 | 40.6 | 29.4 | 36.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
